BUY Piramal Pharma Limited — Siddharth Rai Mangala

Entry₹215.6Inferred
Target₹230
Total upside +6.68% (call closed)
Stop loss₹209-3.06% risk
Exit₹20924 Sept 2026, 1:00 pm
Stop-loss hit-3.06%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Sept 2026
3 supporting1 neutral1 opposing
Supports the BUY call (3)

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·24 Sept · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Sept · 3d ago

Piramal Pharma earns ‘Leader’ ESG rating from independent assessor

NewsGoogle News·18 Sept · 5d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.